Status:
RECRUITING
Molecular Biology of Polycythemia and Thrombocytosis
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Polycythemia
Thrombocytosis
Eligibility:
All Genders
Brief Summary
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these diso...
Detailed Description
Our hypothesis is that genes and their mutation are causative of certain types of polycythemia and thrombocytosis. These will be sought for by genetic and cell biology means. The purpose of the study ...
Eligibility Criteria
Inclusion
- Subjects with an elevated hemoglobin concentration (\>18 in males and \>16 in females)
- Subjects with an elevated platelet count (\>450,000)
Exclusion
- Subjects who have a known acquired cause of polycythemia and thrombocytosis
- Subjects with heart disease, left to right heart shunt or severe pulmonary disease
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00722527
Start Date
July 1 2006
End Date
July 1 2028
Last Update
January 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84132